Tritanrix™- HepB

BIOLOGICAL2 trials

Sponsors

GlaxoSmithKline

Conditions

Infections, Meningococcal

Phase 3

Immune Response & Safety of GSK Biologicals' Mencevax™ ACWY in Subjects Primed in the DTPW-HBV=HIB-MENAC-TT-011 Study

CompletedNCT00291343

GlaxoSmithKlineInfections, Meningococcal

Start: 2006-02-01End: 2007-03-15Updated: 2018-06-06

Study to Asses DTPw-HBV/Hib at 15-18 Months (m) and Mencevax™ ACW at 24 to 30 m in Primed Subjects

CompletedNCT00317109

GlaxoSmithKlineInfections, Meningococcal

Start: 2006-04-19End: 2007-05-17Updated: 2018-06-06